From a cellular pharmacy viewpoint, the medication represents a fascinating case study. Its mechanism of action involves the preferential inhibition of COX enzymes, specifically those catalysts, although with a level of non-selectivity compared to newer agents. This produces a decrease of prostaglandin synthesis, ultimately reducing inflammation an